Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 2073 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 3271 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 3497 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4173 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4218 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4248 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4260 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4277 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4333 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4471 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4505 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4655 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4670 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4844 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4849 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4879 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 4941 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5032 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5091 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5112 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5212 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5234 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5307 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5389 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5452 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5465 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5495 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5656 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5662 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5717 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5758 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5777 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5833 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 5960 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6090 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6117 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6180 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6198 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6219 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6259 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6264 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6285 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6444 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6476 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6493 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6678 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6680 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6710 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6824 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6916 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 6918 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 7210 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 7269 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 7293 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 7504 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 7689 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 7723 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 7738 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 7776 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 7780 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 8056 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 8132 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 8471 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 8600 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 9125 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 9222 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 9394 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 9770 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 10125 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 10554 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 10664 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 10787 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 11196 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 11237 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 11483 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 11824 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 11992 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 12750 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 12751 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 13484 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 13486 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 13570 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 13658 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 13875 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 13910 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 14044 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 14283 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 15016 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 15226 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 15744 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 15892 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 16623 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 16762 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 17443 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 18031 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 20646 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 34927 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | 2064 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | 2481 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | 4965 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 2073 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 2455 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 3384 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 3497 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4173 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4218 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4248 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4260 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4277 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4333 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4505 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4601 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4655 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4670 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4844 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4849 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4879 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 4941 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5032 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5091 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5112 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5212 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5234 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5300 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5307 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5352 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5389 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5452 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5465 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5495 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5639 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5717 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5758 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5777 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5833 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 5960 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6090 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6117 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6180 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6219 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6259 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6264 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6285 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6331 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6444 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6476 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6493 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6678 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6710 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6824 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 6880 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Return to search page